Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis by K. Melissa Hallow, K. Melissa Hallow, Peter J. Greasley, Hiddo J. L. Heerspink, Hiddo J. L. Heerspink, Hongtao Yu

Get full text

The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity by Hiddo J.L. Heerspink, Zeqing Lu, Yu Du, Kevin L. Duffin, Tamer Coskun, Axel Haupt, Mark L. Hartman

Get full text

WCN24-1550 ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL by Katherine Tuttle, Sibylle Hauske, Shimoli V. Shah, Lisa Cronin, Zhichao Sun, Dick de Zeeuw, Hiddo J.L. Heerspink, Peter Rossing

Get full text

WCN24-1868 ASSIST: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I by Irene L. Noronha, Jonathan Barratt, Jose Luis Górriz, Sradha Kotwal, Soo Kun Lim, Valeria Beckett, Marianne Camargo, Amy K. Mottl, Hiddo J.L. Heerspink

Get full text

WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN by Hiddo J.L. Heerspink, Meg Jardine, Donald E. Kohan, Richard A. Lafayette, Adeera Levin, Adrian Liew, Hong Zhang, Todd Gray, Khushboo Sheth, Marianne Camargo, Ronny Renfurm, Andrew King, Jonathan Barratt

Get full text

WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY by Hiddo J.L. Heerspink, David C. Wheeler, Ricardo Correa-Rotter, Jamie P. Dwyer, Anna Maria Langkilde, Patrick B. Mark, Michal Nowicki, Peter Rossing, Robert D. Toto, Glenn M. Chertow, Niels Jongs

Get full text

Erratum to “Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1283-1287]... by Sean J. Barbour, Rosanna Coppo, Jonathan Barratt, Lee Er, Richard Lafayette, Hiddo J.L. Heerspink, Dana V. Rizk, Adrian Liew, Vivekanand Jha, Hong Zhang, Yusuke Suzuki, Hernan Trimarchi, Daniel C. Cattran

Get full text

Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts by Sean J. Barbour, Rosanna Coppo, Jonathan Barratt, Lee Er, Richard Lafayette, Hiddo J.L. Heerspink, Dana V. Rizk, Adrian Liew, Vivekanand Jha, Hong Zhang, Yusuke Suzuki, Hernan Trimarchi, Daniel C. Cattran

Get full text

Corrigendum to “Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy” [Volume 10, Issue 1, January 2025,... by Hiddo J.L. Heerspink, Meg Jardine, Donald E. Kohan, Richard A. Lafayette, Adeera Levin, Adrian Liew, Hong Zhang, Irene Noronha, Hernan Trimarchi, Fan Fan Hou, Ronny Renfurm, Todd Gray, Marianne Camargo, Jonathan Barratt

Get full text

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy by Hiddo J.L. Heerspink, Meg Jardine, Donald E. Kohan, Richard A. Lafayette, Adeera Levin, Adrian Liew, Hong Zhang, Irene Noronha, Hernan Trimarchi, Fan Fan Hou, Ronny Renfurm, Todd Gray, Marianne Camargo, Jonathan Barratt

Get full text

Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial by Akihiko Koshino, Brendon L. Neuen, Megumi Oshima, Tadashi Toyama, Akinori Hara, Clare Arnott, Bruce Neal, Meg Jardine, Sunil V. Badve, Kenneth W. Mahaffey, Carol Pollock, Michael K. Hansen, Takashi Wada, Hiddo J.L. Heerspink

Get full text

Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease by Alexis Hofherr, Elena Liarte Marin, Barbara Musial, Asha Seth, Tim Slidel, James Conway, David Baker, Pernille B.L. Hansen, Benjamin Challis, Stefano Bartesaghi, Maria Bhat, Roberto Pecoits-Filho, Xiao Tu, Viknesh Selvarajah, Kevin Woollard, Hiddo J.L. Heerspink

Get full text

Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure by Yuliya Lytvyn, Rosalie A. Scholtes, Eva M. Boorsma, Vikas S. Sridhar, Luxcia Kugathasan, Hongyan Liu, Leif E. Lovblom, Louis Handoko, Charlotte M. Mosterd, John S. Floras, Kevin Burns, Tosin Osuntokun, Adriaan Voors, Daniel H. vanRaalte, Hiddo J. L. Heerspink, David Z. I. Cherney

Get full text

Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study by Howard Trachtman, Jai Radhakrishnan, Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt, Hiddo J.L. Heerspink, Irene L. Noronha, Vlado Perkovic, Brad Rovin, Hernán Trimarchi, Muh Geot Wong, Alex Mercer, Jula Inrig, William Rote, Ed Murphy, Patricia W. Bedard, Sandra Roth, Stewart Bieler, Radko Komers

Get full text

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes by Oliver Schnell, Jaime Almandoz, Lisa Anderson, Katharine Barnard-Kelly, Tadej Battelino, Matthias Blüher, Luca Busetto, Doina Catrinou, Antonio Ceriello, Xavier Cos, Thomas Danne, Colin M. Dayan, Stefano Del Prato, Beatriz Fernández-Fernández, Paola Fioretto, Thomas Forst, James R. Gavin, Francesco Giorgino, Per-Henrik Groop, Igor A. Harsch, Hiddo J. L. Heerspink, Lutz Heinemann, Mahmoud Ibrahim, Michel Jadoul, Sarah Jarvis, Linong Ji, Naresh Kanumilli, Mikhail Kosiborod, Ulf Landmesser, Sofia Macieira, Boris Mankovsky, Nikolaus Marx, Chantal Mathieu, Barbara McGowan, Tatjana Milenkovic, Othmar Moser, Dirk Müller-Wieland, Nikolaos Papanas, Dipesh C. Patel, Andreas F. H. Pfeiffer, Dario Rahelić, Helena W. Rodbard, Lars Rydén, Elke Schaeffner, C. Wendy Spearman, Alin Stirban, Frank Tacke, Pinar Topsever, Luc Van Gaal, Eberhard Standl

Get full text